Related references
Note: Only part of the references are listed.Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
S. Kreuz et al.
MOLECULAR CANCER (2015)
PIM Kinase Inhibitor AZD1208 for Treatment of MYC-Driven Prostate Cancer
Austin N. Kirschner et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma
M. Hiasa et al.
LEUKEMIA (2015)
PhosphoNetworks: a database for human phosphorylation networks
Jianfei Hu et al.
BIOINFORMATICS (2014)
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Erika K. Keeton et al.
BLOOD (2014)
Allele-Specific Imbalance of Oxidative Stress-Induced Growth Inhibitor 1 Associates With Progression of Hepatocellular Carcinoma
Ming Liu et al.
GASTROENTEROLOGY (2014)
Maelstrom Promotes Hepatocellular Carcinoma Metastasis by Inducing Epithelial-Mesenchymal Transition by Way of Akt/GSK-3β/Snail Signaling
Lulu Liu et al.
HEPATOLOGY (2014)
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity
Yuki Kagoya et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
PIM2 Kinase Is Induced by Cisplatin in Ovarian Cancer Cells and Limits Drug Efficacy
Daniele Musiani et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation
Jing Lu et al.
BLOOD (2013)
Pim2 is required for maintaining Multiple Myeloma cell proliferation through modulating mTORC1 pathway.
Jing Lu et al.
CANCER RESEARCH (2013)
SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice
Yan Li et al.
GASTROENTEROLOGY (2013)
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
Lei Lei Chen et al.
NATURE MEDICINE (2013)
Increased expression of PIM-2 and NF-κB genes in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) is associated with complete remission rate and overall survival
Katarzyna Kapelko-Slowik et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells
J. Asano et al.
LEUKEMIA (2011)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Down-Regulation of Tyrosine Aminotransferase at a Frequently Deleted Region 16q22 Contributes to the Pathogenesis of Hepatocellular Carcinoma
Li Fu et al.
HEPATOLOGY (2010)
Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway
Ke Ren et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
PIM2 Induced COX-2 and MMP-9 Expression in Macrophages Requires PI3K and Notch1 Signaling
Kushagra Bansal et al.
PLOS ONE (2009)
Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma
Ning-Fang Ma et al.
HEPATOLOGY (2008)
Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2
Marion Dorsch et al.
CELLULAR SIGNALLING (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
PS Hammerman et al.
BLOOD (2005)
The Pim kinases control rapamycin-resistant T cell survival and activation
CJ Fox et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Lymphocyte transformation by Pim-2 is dependent on nuclear factor-κB activation
PS Hammerman et al.
CANCER RESEARCH (2004)
The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death
B Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor
CJ Fox et al.
GENES & DEVELOPMENT (2003)
Hepatocellular carcinoma
S Badvie
POSTGRADUATE MEDICAL JOURNAL (2000)
Share Paper
